MedTech News
Hyperfine Secures FDA Clearance for Optive AI™ Software, Revolutionizing Swoop® MRI Imaging
New AI-driven software delivers unprecedented image quality improvements, enhancing diagnostic accuracy and expanding the capabilities of portable MRI technology.
Siemens Healthineers Deploys First Mobile Stroke Unit with Onboard CT Scanner in U.S.
Revolutionary SOMATOM On.site Technology Brings Rapid, Hospital-Grade Stroke Diagnosis Directly to Patients in the Field
Electronic face tattoo can gauge mental strain
Researchers gave participants face tattoos that can track when their brain is working too hard. Published in the journal Device, the study introduces a non-permanent wireless forehead e-tattoo that decodes brainwaves to measure mental strain without bulky headgear.
Next-gen biobattery shrinks tumor, paving way for drug-free cancer treatments
A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients.
Algorithm enables more advanced imaging of cardiac tissue and vessels
Cardiovascular diseases cause one death every 33 seconds in America. Diagnosing these conditions, which account for approximately 20% of all deaths annually, can be difficult because the overlaying and natural fluorescence of cardiac tissue complicate diagnostic images.
This Detailed Map of a Human Cell Could Help Us Understand How Cancer Develops
Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.
Darmiyan Receives FDA Approval for Post-Market Surveillance Study of BrainSee, the First-in-Class Clinical Test for Predicting Risk of Progression to Clinical Alzheimer’s Disease
SAN FRANCISCO, May 29, 2025 /PRNewswire/ — Darmiyan, Inc., a leading brain health technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s post-market surveillance study for BrainSee, its groundbreaking clinical prognostic tool for Alzheimer’s disease. This 7-year study aims to further validate the safety and effectiveness of BrainSee in a socio-demographically diverse patient population across the United States. The insights gained will also support pharmaceutical companies and contract research organizations (CROs) in identifying optimal candidates for next-generation Alzheimer’s clinical trials—advancing both precision and equity in patient selection.
Olympus Announces Launch of New Endoscope Drying Cabinet
CENTER VALLEY, Pa., May 29, 2025 /PRNewswire/ — Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the launch of the ScopeLocker Air endoscope drying cabinet, offering a new drying option for healthcare facilities.